Data from Western populations showed that, for every 0.4-mg/mmol increase in the urine albumin-to-creatinine ratio (UACR), the risk of a composite of CV events (i.e., MI, stroke, or CV mortality) increased by 5.9%, regardless of the diagnosis of T2DM [58]. This evidence concerns the gene ALB and Stroke.